May 9, 2016

Posted by in Stock Reports | 0 Comments

Stocks Seeing Recent Insider Sells: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), RR Donnelley & Sons Co (NASDAQ:RRD), Stryker Corporation (NYSE:SYK)

Stocks Seeing Recent Insider Sells: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), RR Donnelley & Sons Co (NASDAQ:RRD), Stryker Corporation (NYSE:SYK)

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) saw an insider sell on May 4, 2016 that may make shareholders worried. BOGER JOSHUA S, director, sold 5,130 shares at $81.02 a piece. The total sale came to $415,640, leaving the total count to 265,284 shares. Its shares currently owned by company management are 0.40% while institutional investors own about 99.00%. The 6-month change recorded in total insider ownership was -24.54%. On the other side, 3.29% change in total institutional ownership has been reported for the 3-month period.

Moving on to the second insider trade which involved HAMILTON JUDITH H, a director at RR Donnelley & Sons Co (NASDAQ:RRD) sold 20,000 shares at $16.60 per share to trim the total holding at 86,177 shares. Its shares currently owned by company management are 1.50% while institutional investors own about 83.50%. The 6-month change recorded in total insider ownership was -0.63%. On the other side, -0.40% change in total institutional ownership has been reported for the 3-month period.

Stryker Corporation (NYSE:SYK) also received some insider trading action as STRYKER RONDA E, who the company’s Director is sold some 6,000 shares at a price of $109.92 per share to the holding that now comprises of 8,076,233 shares. Its shares currently owned by company management are 0.40% while institutional investors own about 74.90%. The 6-month change recorded in total insider ownership was -33.27%. On the other side, -0.70% change in total institutional ownership has been reported for the 3-month period.

 

 

 

 

 

 

Comments are closed.